2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$13.68+$0.79 (+6.14%)
Price as of Aug 03, 2026 3:21 PM EDT- $439.5MMarket Cap
- 43.38%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$13.68+$0.79 (+6.14%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.89 | ||
Change | -$0.86 (-6.25%) | ||
Open | $13.74 | ||
High | $13.74 | ||
Low | $12.66 | ||
Previous Close | $13.75 | ||
Volume | 332,031 | ||
30-Day Average Volume | 184,772 | ||
1-Week Change | -12.96% | ||
1-Month Change | -18.88% | ||
1-Year Change | 43.38% | ||
3-Year Change | 210.60% | ||
5-Year Change | -39.48% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $98.9M | ||
Market Cap | $439.5M | ||
Enterprise Value | $483.7M | ||
Period: QTR TTM FY | |||
Revenue | $22.1M | ||
Net Income | -$6.7M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.2M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $70.8M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -94 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 30 | ||
P/E | -64 | ||
PEG | 0 | ||
Price/Free Cash Flow | -73 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue